Integra LifeSciences saw $282.2M Q2 revenue — 6 observations

Written by Megan Wood | July 26, 2017 | Print  | Email

Integra LifeSciences reported its financial results for the second quarter of 2017.

Here are six observations:

 

1. Revenue increased 13.2 percent in the second quarter of 2017, compared to the same period the year prior, hitting $282.2 million.

 

2. The company's second quarter GAAP gross margin rose 80 basis points to 64.9 percent compared to the second quarter of 2016.

 

3. The second quarter GAAP net income fell to $10.8 million, due to acquisition and integration expenses.

 

4. Integra LifeSciences' operating cash flow was valued at $28.9 million, reflecting a decrease from the same period the year prior.

 

5. The company updated its 2017 revenue guidance to a range of $1.125 billion to $1.14 billion.

 

6. Additionally, Integra LifeSciences' is updating its 2017 full-year organic sales growth to between 6 percent and 7 percent.

 

More articles on devices:
Spinal Kinetics hits 50k+ procedures with M6 cervical, lumbar discs: 4 key notes
Smith & Nephew partners with Memphis medical device accelerator: 5 takeaways
Providence Medical Technology receives Australian regulatory approval: 4 insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.